6 Related NICE guidance
-
Rituximab for the treatment of follicular lymphoma. NICE technology appraisal guidance 110 (2006). [Replaced by NICE technology appraisal guidance 243]
-
Rituximab for aggressive non-Hodgkin's lymphoma. NICE technology appraisal guidance 65 (2003).